Please login to the form below

Not currently logged in


This page shows the latest compliance news and features for those working in and with pharma, biotech and healthcare.

IQVIA partners with Box

IQVIA partners with Box

managing ‘complex’compliance requirements.

Latest news

  • 2018 by Darwin 2018 by Darwin

    It will punish, with extinction, those firms that either reject their implants or allow them to overpower routines, such as compliance, that are essential in our industry.

  • The new basics The new basics

    All firms operate within a legal and regulatory framework in order to have a licence to operate but this is especially true of our industry with its regulated products, high compliance

  • First Herceptin biosimilar cleared in Europe First Herceptin biosimilar cleared in Europe

    Biocon and Mylan withdrew the filing for their biosimilar in the EU, after questions were raised about manufacturing quality compliance issues, but said recently these have been resolved, putting a

  • Takeda Italia takes home digital innovation prize at Le Fonti Awards 2017 Takeda Italia takes home digital innovation prize at Le Fonti Awards 2017

    More specifically, hospitals can create a website to provide doctors with information about their post-discharge patients, including the patient’s compliance history and their quality of life.

  • First digital medicine approved in the US First digital medicine approved in the US

    The company has also been working with Novartis on using the technology to assist compliance with anti-rejection drugs given after organ transplantation. ... In a statement, the FDA cautioned that labelling for Abilify MyCite “notes that the ability of

More from news
Approximately 6 fully matching, plus 520 partially matching documents found.

Latest Intelligence

  • Implementing eHealth innovation Implementing eHealth innovation

    A breakthrough to unlock adherence. Medication adherence often defines effectiveness of a treatment programme and improving patients’compliance with their medicine can be the single most impactful intervention for improving health

  • Bridging pharma’s digital gap Bridging pharma’s digital gap

    Aside from the need to negotiate regulatory barriers compliance rules, David Bennett, Veeva’s European VP for commercial content strategy, has other suggestions. ... Typically, companies have a set of relationships with different agencies, and the

  • Significant figures Significant figures

    Another issue surrounding the diagnosis of NTMs is that physicians can be hesitant to prescribe such a cumbersome treatment with a relatively low compliance rate to their patients, many of whom

  • Healthcare systems

    Healthcare terms - Healthcare systems.

  • A catalyst for change A catalyst for change

    In addition, liabilities for non-compliance under the Policy are much stricter than before. ... independently. Stricter liabilities for non-compliance. The Policy, Law and Measures clarified the liabilities for non-compliance during the drug approval

More from intelligence
Approximately 5 fully matching, plus 73 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 48 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 11 fully matching, plus 99 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Market Access Transformation

MAT offers an information exchange called Rapid Payer Response that allows healthcare stakeholders to secure immediate, global, expert insight and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...